Been following IMU for years, as like everyone, I’d love to see some cancer drugs that work, and also like to make some money by owning it. BUT, and this is a big BUT, unlike stocks like OPT and TLX that have very serious biotech funds on their register and many very knowledgeable biotech analysts supporting them, I see no such thing with IMU. It just appears retail and some small hedge funds - love to be proved wrong. Please, someone, enlighten me on what heavy hitting quality funds own this, and are out in the press talking about it.
thnaks
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
1.3¢ |
Change
0.002(18.2%) |
Mkt cap ! $97.07M | |||
| Open | High | Low | Value | Volume |
| 1.2¢ | 1.4¢ | 1.1¢ | $625.7K | 50.56M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 20 | 5795292 | 1.2¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 1.3¢ | 3258567 | 9 |
View Market Depth
| Last trade - 16.10pm 27/06/2025 (20 minute delay) ? |
| IMU (ASX) Chart |